A tight belt, a harder lift
Can you expect less fat or more strength?
A tight belt or a bag that's harder to lift can worry you. Tests of MOTS-c and tesamorelin measured different changes. Which findings concern people, and which concern animals?
Where did MOTS-c improve strength?
MOTS-c is a 16-amino-acid peptide: its joined parts also make proteins. Your body makes MOTS-c. Animal studies checked sugar use and movement; extra MOTS-c hasn't proved a benefit in people.
Find out how the mice changed »
Who benefited from tesamorelin?
Tesamorelin reduced deep belly fat with one HIV-related problem. The approval covers those adults and that problem. Your cause of weight gain may fall outside this proven use.
Find out who lost belly fat »Which benefit has been shown in people?
Tesamorelin has the human fat-loss result. MOTS-c has no human trial proving treatment helps. Tesamorelin helped people with one HIV-related fat problem. You can't assume that includes your reason for gaining fat. Your body makes MOTS-c; tesamorelin is made in a lab. Where either comes from doesn't tell you whether extra amounts help.
The catch is who was tested.
In lab tests, MOTS-c changed sugar and fat use within muscle cells. Cells are the living pieces that form your body. Tesamorelin makes the pituitary gland below your brain release growth hormone. A hormone carries messages in blood to other body parts. Growth hormone helps break down stored fat. The strongest effect concerns deep belly fat. The approved use concerns uneven fat changes with HIV that leave excess belly fat. Approval doesn't cover weight gain in general.
You'll read findings from published studies here. We don't sell peptides or provide care. Human MOTS-c treatment tests are missing, leaving benefit and harm unproved. The stronger tesamorelin findings still leave your own health questions unanswered.
What would prove that a peptide helped you?
A cell change isn't enough. A treatment needs testing in people who have the problem being claimed. Proteins do many jobs, from helping digestion to controlling hunger. Collagen gives tissues strength. Collagen is a protein too. Proteins contain joined amino acids; peptides have fewer of those joined parts. Peptides can change how cells work. That alone can't prove treatment helps you.
A human test needs a fair comparison.
In some trials, people receive either the drug or placebo. Placebo is a dummy medicine without the active drug being tested. Comparing the groups helps separate a drug's effect from other changes. Lab work tests living cells in dishes or uses animals. Your whole body may respond differently from a cell in a dish.
MOTS-c lacks a formal trial proving benefit in people. Tesamorelin completed Phase 3, large trials carried out before approval. In one test, adults with HIV received 2 milligrams daily. Milligrams measure a small weight of medicine. Compared with placebo, their belly scans showed 42 square centimeters less fat. Square centimeters measure area: here, the fat seen in a belly slice. You can't read lost pounds or easier daily tasks from this area measurement. The trial amount isn't a safe amount established for you.
What happened to belly fat and muscle strength?
You're looking at two different tests: one gave treatment to people with a particular fat problem, and the other gave extra MOTS-c to mice whose muscles then worked better. A mouse gripping harder doesn't tell you whether you'd lift more easily. Less fat on a scan can't establish that the person felt better.
Put the human fat finding first.
- Tesamorelin copies the message for the gland to release growth hormone. A small chemical addition helps the drug resist breakdown [9]. Five trials tested adults whose HIV treatment was linked to uneven fat gain and loss. Fat near their belly organs fell. The average difference on scans was roughly 28 square centimeters. That measures fat area, not lost pounds. Researchers measured the liver's fat percentage before and after treatment. That percentage fell by about 4% [8]. The figure is the gap between those readings. Fat occupied less of the liver afterward. The figure isn't the amount of starting fat removed. Approval covers this HIV-related problem; sport rules ban the drug.
- MOTS-c is a 16-amino-acid peptide made within your cells' energy-producing parts. Amino acids also join together to make proteins. Lab tests found that MOTS-c slowed steps involving folate, a vitamin. Sugar entered the muscle cells more readily; the cells burned more fat [6]. Exercise raised blood MOTS-c levels. Extra MOTS-c helped mice move and grip better at different ages [4]. Human studies measured existing blood levels and later health. Those people weren't given MOTS-c to see whether treatment helped.
You can check both sets of findings together. Neither result promises a change in your waist or strength.
How far can you trust a health claim?
Check who the finding concerns. A promise about your waist may go further than a study of one HIV-related problem. Approval doesn't make every use of tesamorelin approved. Nor can a mouse result establish MOTS-c benefit for you.
The tested group sets the limit.
Use the small number after the finding to locate the paper. Other researchers checked these journal papers before they appeared. Some describe a new test; reviews gather tests already done. A review adds no newly treated patients. Those differences help you see what backs a claim.
A blood reading can go with illness without causing that illness. Before a claim can tell you what raising a blood reading would do, researchers have to give people treatment and check whether their health changes because of that treatment. An animal result or a blood-test link still leaves your health questions open. These studies don't provide directions for care.